Novo Nordisk AS (NVO)
85.00
-18.44
(-17.83%)
USD |
NYSE |
Dec 20, 16:00
86.00
+1.00
(+1.18%)
After-Hours: 20:00
Novo Nordisk Shareholders Equity (Quarterly): 18.05B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ascendis Pharma AS | -108.70M |
| Evaxion Biotech AS | 0.074M |
| Amgen Inc | 7.527B |
| Viking Therapeutics Inc | 911.45M |
| Akari Therapeutics PLC | -6.694M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.53B |
| Total Liabilities (Quarterly) | 41.48B |
| Debt to Equity Ratio | 0.4727 |
| Current Ratio | 0.9367 |
| Net Debt Paydown Yield | -0.18% |